Anonymous
Guest
Anonymous
Guest
Do you think they will just hire a contract company to launch this product if it does get approved this year ?? It would be much more cost effective and could even pay those reps less than what they are paying us.
It will never get that far. There are just "prettying up this pig" to sell it to someone else. The plan is they will get a year out from launch then sell this shit hole to another company who will launch combo and dump all of us. Just watch.
You think the Swiss want out that bad? I thought they had major hard ons to get into the US markets. I think they anticipate a lot more people leaving, which is why I cant believe they shelled out on a POA. With the current model, they can keep cycling in right-out-of-college newbies at pennies and bringing costs further and further down. If anything I say Bala sticks around another year or two in order to show the last few hold ons out the door. Then when costs are at their absolute lowest, hell cash in on his short sighted scumbag deal and jet before Switzerland realizes Meda cant even move a single rx of what ever horse shit they have bought at the time. Then he moves to his next a little too big for their britches pharma company to slash and burn and the circle of life continues. Can anyone say over expanding like MedPointe circa 2006 Teva anybody??????